New study investigates chewing and swallowing problems in scleroderma patients
NCT ID NCT07182981
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how scleroderma affects chewing and swallowing in both children and adults. Researchers will use questionnaires and physical tests to measure these functions and understand the overall well-being of participants. The goal is to find better tools for assessing these issues and improve disease management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify better ways to assess chewing and swallowing problems in people with scleroderma, leading to improved care.
- What could go wrong
- This is an observational study with only 50 participants, so findings may not apply to everyone with scleroderma. It does not test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hacettepe University
RECRUITINGÇankaya, Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can skin biopsies unlock new treatments for scleroderma?
- Could a skin patch ease stomach pain in scleroderma?
- Could a painless microneedle pad ease Raynaud's in scleroderma?
- Can a new pill ease the hardening skin of systemic sclerosis?
- A drug after transplant may stop scleroderma from coming back
- Can a single drug calm three different autoimmune diseases? a new trial puts ATG-201 to the test.